{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:53:00Z","timestamp":1741067580031,"version":"3.38.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009451","name":"Osteopathic Heritage Foundation","doi-asserted-by":"publisher","award":["R01DK124126","R01DK054254"],"award-info":[{"award-number":["R01DK124126","R01DK054254"]}],"id":[{"id":"10.13039\/100009451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R21AA027633"],"award-info":[{"award-number":["R21AA027633"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P42ES04699"],"award-info":[{"award-number":["P42ES04699"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-KPQ-107-TCPMP"],"award-info":[{"award-number":["AS-KPQ-107-TCPMP"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017995","name":"Nora Eccles Treadwell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK124126"],"award-info":[{"award-number":["R01DK124126"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.biopha.2024.116590","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T15:56:35Z","timestamp":1713801395000},"page":"116590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacological inhibition of the Src homology phosphatase 2 confers partial protection in a mouse model of alcohol-associated liver disease"],"prefix":"10.1016","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8504-8297","authenticated-orcid":false,"given":"Ming-Fo","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia M.","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Ching","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawaz G.","family":"Haj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"5","author":"Collaborators","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of Liver Disease: 2023 Update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"issue":"17","key":"10.1016\/j.biopha.2024.116590_bib3","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1001\/jama.2022.4308","article-title":"Alcohol-related deaths during the covid-19 pandemic","volume":"327","author":"White","year":"2022","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.biopha.2024.116590_bib4","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/hep.29631","article-title":"Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population","volume":"67","author":"Aberg","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20294","article-title":"Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014-2019","volume":"3","author":"Wong","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.biopha.2024.116590_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1997","article-title":"Trends in the burden of chronic liver disease among hospitalized US Adults","volume":"3","author":"Hirode","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a review","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"issue":"30","key":"10.1016\/j.biopha.2024.116590_bib8","doi-asserted-by":"crossref","first-page":"22771","DOI":"10.1016\/S0021-9258(18)41593-1","article-title":"Expression, purification, and characterization of SH2-containing protein tyrosine phosphatase, SH-PTP2","volume":"268","author":"Sugimoto","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2024.116590_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0092-8674(00)80938-1","article-title":"Crystal structure of the tyrosine phosphatase SHP-2","volume":"92","author":"Hof","year":"1998","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2024.116590_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/MCB.18.1.161","article-title":"Structural determinants of SHP-2 function and specificity in Xenopus mesoderm induction","volume":"18","author":"O'Reilly","year":"1998","journal-title":"Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1097-2765(04)00050-4","article-title":"Shp2 regulates SRC family kinase activity and Ras\/Erk activation by controlling Csk recruitment","volume":"13","author":"Zhang","year":"2004","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/MCB.01661-08","article-title":"Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death","volume":"29","author":"Princen","year":"2009","journal-title":"Mol. Cell Biol."},{"issue":"51","key":"10.1016\/j.biopha.2024.116590_bib13","doi-asserted-by":"crossref","first-page":"39750","DOI":"10.1074\/jbc.M110.153734","article-title":"Altered glucose homeostasis in mice with liver-specific deletion of Src homology phosphatase 2","volume":"285","author":"Matsuo","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2024.116590_bib14","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4155\/fmc.14.88","article-title":"Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention","volume":"6","author":"Butterworth","year":"2014","journal-title":"Future Med Chem."},{"issue":"21","key":"10.1016\/j.biopha.2024.116590_bib15","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/0008-5472.CAN-17-1510","article-title":"Therapeutic Targeting of Oncogenic Tyrosine Phosphatases","volume":"77","author":"Frankson","year":"2017","journal-title":"Cancer Res"},{"issue":"17","key":"10.1016\/j.biopha.2024.116590_bib16","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1021\/acs.jmedchem.6b00680","article-title":"Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor","volume":"59","author":"Garcia Fortanet","year":"2016","journal-title":"J. Med Chem."},{"issue":"7610","key":"10.1016\/j.biopha.2024.116590_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nature18621","article-title":"Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases","volume":"535","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biopha.2024.116590_bib18","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41591-018-0022-x","article-title":"Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition","volume":"24","author":"Wong","year":"2018","journal-title":"Nat. Med"},{"issue":"7","key":"10.1016\/j.biopha.2024.116590_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41591-018-0023-9","article-title":"SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo","volume":"24","author":"Mainardi","year":"2018","journal-title":"Nat. Med"},{"issue":"11","key":"10.1016\/j.biopha.2024.116590_bib20","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/neuonc\/noz107","article-title":"Targeting PDGFRalpha-activated glioblastoma through specific inhibition of SHP-2-mediated signaling","volume":"21","author":"Sang","year":"2019","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.apsb.2018.08.009","article-title":"SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade","volume":"9","author":"Zhao","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biopha.2024.116590_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.30989","article-title":"Overriding adaptive resistance to sorafenib through combination therapy with src homology 2 domain-containing phosphatase 2 blockade in hepatocellular Carcinoma","volume":"72","author":"Leung","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib23","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3892\/mmr.2020.11324","article-title":"Combined administration of SHP2 inhibitor SHP099 and the alpha7nAChR agonist PNU282987 protect mice against DSSinduced colitis","volume":"22","author":"Xiao","year":"2020","journal-title":"Mol. Med Rep."},{"issue":"31","key":"10.1016\/j.biopha.2024.116590_bib24","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1074\/jbc.RA119.011840","article-title":"Disrupting phosphatase SHP2 in macrophages protects mice from high-fat diet-induced hepatic steatosis and insulin resistance by elevating IL-18 levels","volume":"295","author":"Liu","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2024.116590_bib25","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1042\/BST20201308","article-title":"Functional interrogation and therapeutic targeting of protein tyrosine phosphatases","volume":"49","author":"Krabill","year":"2021","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.biopha.2024.116590_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.alcohol.2023.04.002","article-title":"Alcohol and immunology: mechanisms of multi-organ damage. summary of the 2022 alcohol and immunology research interest group (airig) meeting","volume":"110","author":"McMahan","year":"2023","journal-title":"Alcohol"},{"issue":"26","key":"10.1016\/j.biopha.2024.116590_bib27","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.3748\/wjg.v24.i26.2785","article-title":"Liver transplantation and alcoholic liver disease: History, controversies, and considerations","volume":"24","author":"Marroni","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116590_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12272-022-01392-4","article-title":"Alcoholic liver disease: a new insight into the pathogenesis of liver disease","volume":"45","author":"Park","year":"2022","journal-title":"Arch. Pharm. Res"},{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bbamem.2007.08.018","article-title":"Crosstalk of tight junction components with signaling pathways","volume":"1778","author":"Gonzalez-Mariscal","year":"2008","journal-title":"Biochim Biophys. Acta"},{"issue":"5","key":"10.1016\/j.biopha.2024.116590_bib30","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.3390\/ijms22052506","article-title":"Tight Junctions as a Key for Pathogens Invasion in Intestinal Epithelial Cells","volume":"22","author":"Paradis","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116590_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/807356","article-title":"Modulation of tight junction structure and function by kinases and phosphatases targeting occludin","author":"Dorfel","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/CS20171055","article-title":"Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease","volume":"132","author":"Starkel","year":"2018","journal-title":"Clin. Sci. (Lond. )"},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/molecules28020619","article-title":"Leaky gut and the ingredients that help treat it: a review","volume":"28","author":"Aleman","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.biopha.2024.116590_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109974","article-title":"Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment","volume":"37","author":"Chen","year":"2021","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2014.05.020","article-title":"Cytoplasmic tyrosine phosphatase Shp2 coordinates hepatic regulation of bile acid and FGF15\/19 signaling to repress bile acid synthesis","volume":"20","author":"Li","year":"2014","journal-title":"Cell Metab."},{"issue":"591","key":"10.1016\/j.biopha.2024.116590_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe2587","article-title":"SHP2 drives inflammation-triggered insulin resistance by reshaping tissue macrophage populations","volume":"13","author":"Paccoud","year":"2021","journal-title":"Sci. Transl. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.116590_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcmgh.2015.11.001","article-title":"New and unexpected biological functions for the src-homology 2 domain-containing phosphatase shp-2 in the gastrointestinal tract","volume":"2","author":"Coulombe","year":"2016","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nprot.2013.032","article-title":"Mouse model of chronic and binge ethanol feeding (the NIAAA model)","volume":"8","author":"Bertola","year":"2013","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.biopha.2024.116590_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.biopha.2024.116590_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061217","article-title":"phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data","volume":"8","author":"McMurdie","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ismej.2010.133","article-title":"UniFrac: an effective distance metric for microbial community comparison","volume":"5","author":"Lozupone","year":"2011","journal-title":"ISME J."},{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/biomedicines7030068","article-title":"Alcoholic Liver Disease: Current Mechanistic Aspects with Focus on Their Clinical Relevance","volume":"7","author":"Teschke","year":"2019","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib43","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ajpath.2011.11.017","article-title":"Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis","volume":"180","author":"Zhong","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116590_bib44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrgastro.2017.116","article-title":"Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations","volume":"15","author":"Parker","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2018.10.037","article-title":"Effect of ethanol on lipid metabolism","volume":"70","author":"You","year":"2019","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116590_bib46","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1530-0277.2011.01577.x","article-title":"Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats","volume":"35","author":"Aroor","year":"2011","journal-title":"Alcohol Clin. Exp. Res"},{"issue":"11","key":"10.1016\/j.biopha.2024.116590_bib47","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.3390\/ijms21113796","article-title":"Liver fibrosis and inflammation under the control of ERK2","volume":"21","author":"Jeng","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/jhep.2002.31169","article-title":"Expression of interferon alfa signaling components in human alcoholic liver disease","volume":"35","author":"Nguyen","year":"2002","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.biopha.2024.116590_bib49","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/jcm10143011","article-title":"Oxidative Stress-A Key Player in the Course of Alcohol-Related Liver Disease","volume":"10","author":"Michalak","year":"2021","journal-title":"J. Clin. Med"},{"issue":"7","key":"10.1016\/j.biopha.2024.116590_bib50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4254\/wjh.v12.i7.332","article-title":"Oxidative stress in alcohol-related liver disease","volume":"12","author":"Tan","year":"2020","journal-title":"World J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib51","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.32562","article-title":"Endoplasmic reticulum stress in liver diseases","volume":"77","author":"Ajoolabady","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116590_bib52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hep.27383","article-title":"Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice","volume":"61","author":"Lazaro","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116590_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4291\/wjgp.v7.i1.17","article-title":"Adipose tissue-liver axis in alcoholic liver disease","volume":"7","author":"Wang","year":"2016","journal-title":"World J. Gastrointest. Pathophysiol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116590_bib54","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.7150\/thno.55795","article-title":"Organ-organ communication: the liver's perspective","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/biom7030062","article-title":"Organ-organ crosstalk and alcoholic liver disease","volume":"7","author":"Poole","year":"2017","journal-title":"Biomolecules"},{"issue":"1086","key":"10.1016\/j.biopha.2024.116590_bib56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/postgradmedj-2015-133755","article-title":"Cardiac manifestations in alcoholic liver disease","volume":"92","author":"Milic","year":"2016","journal-title":"Post. Med J."},{"issue":"11","key":"10.1016\/j.biopha.2024.116590_bib57","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/neuonc\/noz176","article-title":"An allosteric inhibitor of SHP2 effectively targets PDGFRalpha-driven glioblastoma","volume":"21","author":"Tannous","year":"2019","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib58","article-title":"Gut dysbiosis as a driver in alcohol-induced liver injury","volume":"3","author":"Fairfield","year":"2021","journal-title":"JHEP Rep."},{"issue":"1","key":"10.1016\/j.biopha.2024.116590_bib59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116590_bib60","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gutjnl-2019-319720","article-title":"Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting","volume":"69","author":"Avila","year":"2020","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib61","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/a-2145-7331","article-title":"Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease","volume":"43","author":"Ranjbarian","year":"2023","journal-title":"Semin Liver Dis."},{"issue":"8","key":"10.1016\/j.biopha.2024.116590_bib62","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/jgh.16199","article-title":"Alcohol, the gut microbiome, and liver disease","volume":"38","author":"Jew","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116590_bib63","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/19490976.2020.1736457","article-title":"Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model","volume":"11","author":"Yu","year":"2020","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.biopha.2024.116590_bib64","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2216942","article-title":"Astragaloside IV ameliorate acute alcohol-induced liver injury in mice via modulating gut microbiota and regulating NLRP3\/caspase-1 signaling pathway","volume":"55","author":"Wu","year":"2023","journal-title":"Ann. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.116590_bib65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcmgh.2021.08.014","article-title":"Aryl hydrocarbon receptor deficiency in intestinal epithelial cells aggravates alcohol-related liver disease","volume":"13","author":"Qian","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2024.116590_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175096","article-title":"Ameliorative effects of chlorogenic acid on alcoholic liver injury in mice via gut microbiota informatics","volume":"928","author":"Zhu","year":"2022","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116590_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122451","article-title":"Hepatic protein tyrosine phosphatase Shp2 disruption mitigates the adverse effects of ethanol in the liver by modulating oxidative stress and ERK signaling","volume":"340","author":"Hsu","year":"2024","journal-title":"Life Sci."},{"issue":"15","key":"10.1016\/j.biopha.2024.116590_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159930","article-title":"SHP2 inhibition enhances Yes-associated protein-mediated liver regeneration in murine partial hepatectomy models","volume":"7","author":"Watkins","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.biopha.2024.116590_bib69","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/hep.29803","article-title":"Hepatic stellate cell-derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2","volume":"68","author":"Kostallari","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biopha.2024.116590_bib70","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1002\/2211-5463.12992","article-title":"SHP2 knockdown ameliorates liver insulin resistance by activating IRS-2 phosphorylation through the AKT and ERK1\/2 signaling pathways","volume":"10","author":"Yue","year":"2020","journal-title":"FEBS Open Bio"},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib71","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/ijms23020774","article-title":"Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease","volume":"23","author":"Yang","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"36","key":"10.1016\/j.biopha.2024.116590_bib72","doi-asserted-by":"crossref","first-page":"25727","DOI":"10.1074\/jbc.M113.462291","article-title":"Induction of a tumor-associated activating mutation in protein tyrosine phosphatase Ptpn11 (Shp2) enhances mitochondrial metabolism, leading to oxidative stress and senescence","volume":"288","author":"Zheng","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2024.116590_bib73","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1074\/jbc.M114.614057","article-title":"Protein-tyrosine phosphatase Shp2 positively regulates macrophage oxidative burst","volume":"290","author":"Li","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.116590_bib74","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41598-017-00564-3","article-title":"Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria","volume":"7","author":"Hsu","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2024.116590_bib75","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00018-022-04517-6","article-title":"Deficiency of the Src homology phosphatase 2 in podocytes is associated with renoprotective effects in mice under hyperglycemia","volume":"79","author":"Hsu","year":"2022","journal-title":"Cell Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib76","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ymthe.2018.09.019","article-title":"Loss of Shp2 Rescues BDNF\/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection","volume":"27","author":"Chitranshi","year":"2019","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2024.116590_bib77","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00204-016-1861-1","article-title":"SHP-2 phosphatase controls aryl hydrocarbon receptor-mediated ER stress response in mast cells","volume":"91","author":"Wang","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116590_bib78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.20181198","article-title":"Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10","volume":"216","author":"Xiao","year":"2019","journal-title":"J. Exp. Med"},{"issue":"40","key":"10.1016\/j.biopha.2024.116590_bib79","doi-asserted-by":"crossref","first-page":"65676","DOI":"10.18632\/oncotarget.11601","article-title":"SHP-2 phosphatase contributes to KRAS-driven intestinal oncogenesis but prevents colitis-associated cancer development","volume":"7","author":"Gagne-Sansfacon","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1095\/biolreprod.112.104414","article-title":"The tyrosine phosphatase SHP2 regulates Sertoli cell junction complexes","volume":"88","author":"Puri","year":"2013","journal-title":"Biol. Reprod."},{"issue":"6","key":"10.1016\/j.biopha.2024.116590_bib81","doi-asserted-by":"crossref","first-page":"G1280","DOI":"10.1152\/ajpgi.2001.280.6.G1280","article-title":"Role of protein tyrosine phosphorylation in acetaldehyde-induced disruption of epithelial tight junctions","volume":"280","author":"Atkinson","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib82","doi-asserted-by":"crossref","first-page":"G367","DOI":"10.1152\/ajpgi.00173.2003","article-title":"TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation","volume":"286","author":"Ma","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116590_bib83","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.4049\/jimmunol.178.7.4641","article-title":"IL-1beta causes an increase in intestinal epithelial tight junction permeability","volume":"178","author":"Al-Sadi","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116590_bib84","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1582-4934.2010.01065.x","article-title":"Cellular and molecular mechanism of interleukin-1beta modulation of Caco-2 intestinal epithelial tight junction barrier","volume":"15","author":"Al-Sadi","year":"2011","journal-title":"J. Cell Mol. Med"},{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib85","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1128\/MCB.19.3.2416","article-title":"Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak\/STAT pathway","volume":"19","author":"You","year":"1999","journal-title":"Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116590_bib86","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCRESAHA.108.179754","article-title":"Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase\/Src and mTOR pathways","volume":"103","author":"Marin","year":"2008","journal-title":"Circ. Res"},{"issue":"49","key":"10.1016\/j.biopha.2024.116590_bib87","doi-asserted-by":"crossref","first-page":"19623","DOI":"10.1073\/pnas.1111414108","article-title":"P-glycoprotein regulates blood-testis barrier dynamics via its effects on the occludin\/zonula occludens 1 (ZO-1) protein complex mediated by focal adhesion kinase (FAK)","volume":"108","author":"Su","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2024.116590_bib88","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1074\/jbc.M804783200","article-title":"Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions","volume":"284","author":"Elias","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.biopha.2024.116590_bib89","doi-asserted-by":"crossref","first-page":"14997","DOI":"10.1074\/jbc.M901901200","article-title":"Density-enhanced phosphatase 1 regulates phosphorylation of tight junction proteins and enhances barrier function of epithelial cells","volume":"284","author":"Sallee","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.biopha.2024.116590_bib90","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.3748\/wjg.v28.i36.5280","article-title":"Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease","volume":"28","author":"Warner","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2024.116590_bib91","article-title":"SHP2 Inhibitors Show Anti-Myeloma Activity and Synergize With Bortezomib in the Treatment of Multiple Myeloma","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116590_bib92","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1158\/2159-8290.CD-21-0369","article-title":"Combined Inhibition of SHP2 and CXCR1\/2 Promotes Antitumor T-cell Response in NSCLC","volume":"12","author":"Tang","year":"2022","journal-title":"Cancer Discov."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T19:33:24Z","timestamp":1741030404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224004748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":92,"alternative-id":["S0753332224004748"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116590","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of the Src homology phosphatase 2 confers partial protection in a mouse model of alcohol-associated liver disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116590"}}